# COMT, MAOA, and SLC6A4 Polymorphisms and Inferior Alveolar Nerve Block Success

> **NCT07697300** · NA · COMPLETED · sponsor: **Marmara University** · enrollment: 95 (actual)

## Conditions studied

- Symptomatic Irreversible Pulpitis (SIP)

## Interventions

- **PROCEDURE:** Inferior Alveolar Nerve Block with 4% Articaine

## Key facts

- **NCT ID:** NCT07697300
- **Lead sponsor:** Marmara University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-11-12
- **Primary completion:** 2026-04-02
- **Final completion:** 2026-04-28
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697300, "COMT, MAOA, and SLC6A4 Polymorphisms and Inferior Alveolar Nerve Block Success". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*